摘要
Vivian DE CARVALHO AMARAL 医师
皮肤科医师
Vaginal atrophy vectors (VA) technique for vaginal atrophy
Objectives: The VA technique uses superficial submucosal HA injections in three vectors of the posterior vaginal wall to treat dryness and laxity safely. In 22 women (35–70 y), results showed improved moisture and orgasmic potential. Only one case required hyaluronidase. Recommended: ≤ 1 ml per session, gentle injection, and low–cross-linked HA for atrophic tissue. This method reduces embolism risk and enhances safety and efficacy compared to traditional vaginal HA injections.
Introduction: Vaginal dryness and laxity are frequent complaints among women aged 35–70, often impairing comfort and sexual satisfaction. Traditional hyaluronic acid (HA) techniques may carry embolic risk when injected deeply. The VA technique was developed to improve hydration and elasticity using a safer, superficial submucosal approach, maintaining functional and aesthetic integrity.
Materials / method: Twenty-two women (35–70 y) were treated using the VA technique, which involves low–cross-linked HA injections in three vectors along the posterior vaginal wall. A maximum of 1 ml per session was used, with gentle, submucosal application under local anesthesia. The protocol focused on hydration, elasticity, and safety. Follow-up evaluated comfort, lubrication, and orgasmic response.
Results: All patients reported improvement in vaginal moisture and elasticity, with enhanced orgasmic potential. No major complications occurred; only one patient required hyaluronidase for overcorrection. Tissue tone and hydration increased progressively after a single session, and satisfaction remained high at follow-up. No cases of vascular events or sensitivity loss were observed.
Conclusion: The VA technique is a safe, effective alternative for treating vaginal dryness and laxity. Its submucosal, low-volume approach reduces embolic risk while restoring hydration and sensitivity. Using low–cross-linked HA and precise vectors enhances safety and results. The method offers a predictable, reproducible, and minimally invasive solution for vaginal rejuvenation.
披露 - Vivian DE CARVALHO AMARAL
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2026年 5月 21日 - Recorded during IMCAS Americas 2026